Breaking News, Promotions & Moves

AcuraBio Appoints Guillaume Herry as CEO

Herry brings over 15 years of international operational and strategic consulting experience.

AcuraBio has appointed international biopharma executive Guillaume Herry as CEO.
 
Herry brings over 15 years of international operational and strategic consulting experience across the biopharmaceutical and medical device industries. AcuraBio will immediately benefit from Herry’s experience in designing and implementing growth strategies, as it leverages the business’ deep technical experience to grow the company and expand the service offering.
 
Herry holds an MBA from the Australian Graduate School of Management at University of New South Wales Business School (Australia), a Master’s Degree in Engineering for Health and Drugs (Biotechnology, Health and Management) from the University Joseph Fourier in Grenoble (France) and a Master’s Degree in Entrepreneurship in Life Sciences & Technologies from the University Paris-Sud X (France).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters